U.S. Microfluidics Market Size & Outlook, 2026-2033
Global Market
Related Markets
U.S. microfluidics market highlights
- The U.S. microfluidics market generated a revenue of USD 15,823.2 million in 2025 and is expected to reach USD 37,796.8 million by 2033.
- The U.S. market is expected to grow at a CAGR of 11.4% from 2026 to 2033.
- In terms of segment, microfluidic components was the largest revenue generating product in 2025.
- Microfluidic Components is the most lucrative product segment registering the fastest growth during the forecast period.
Microfluidics market data book summary
| Market revenue in 2025 | USD 15,823.2 million |
| Market revenue in 2033 | USD 37,796.8 million |
| Growth rate | 11.4% (CAGR from 2026 to 2033) |
| Largest segment | Microfluidic components |
| Fastest growing segment | Microfluidic Components |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Microfluidic Components, Microfluidic-based Devices |
| Key market players worldwide | Illumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.7% of the global microfluidics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. microfluidics market is projected to lead the regional market in terms of revenue in 2033.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 3,165.5 million by 2033.
The demand for microfluidics devices is high in the U.S. owing to increasing research undertaken, government funding, and favorable policies. For instance, MEI Lab announced that it was developing organ-on-a-chip digital twin platforms, as well as 3D implantable and transformable electrodes.
The scope of this multiyear project includes assembling 3D structures, optimizing & screening functional materials, and assessing their biocompatibility. Moreover, the FDA’s Center for Devices and Radiological Health (CDRH) is also seeking to advance innovation in medical devices based on microfluidics by developing a regulatory science tool for leakage testing.
Furthermore, microfluidics entails high levels of skill, and therefore, simplifying through machine learning and AI can encourage its broader use in life sciences and healthcare. For instance, Deepcell, with its AI-based single-cell sorting and analysis technology, is among the first companies to bring the combination of machine learning, AI, and microfluidics into the commercial domain.
No credit card required*
Publish Date: Jun 02, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Microfluidics Market Scope
Microfluidics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Standard BioTools Inc | View profile | 539 | 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 | www.standardbio.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
U.S. Microfluidics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Microfluidics Market Outlook will help companies and investors design strategic landscapes.
Microfluidic Components was the largest segment with a revenue share of 88.84% in 2025.
Horizon Databook has segmented the U.S. microfluidics market based on microfluidic components, microfluidic-based devices covering the revenue growth of each sub-segment from 2021 to 2033.
The demand for microfluidics devices is high in the U.S. owing to increasing research undertaken, government funding, and favorable policies. For instance, MEI Lab announced that it was developing organ-on-a-chip digital twin platforms, as well as 3D implantable and transformable electrodes.
The scope of this multiyear project includes assembling 3D structures, optimizing & screening functional materials, and assessing their biocompatibility. Moreover, the FDA’s Center for Devices and Radiological Health (CDRH) is also seeking to advance innovation in medical devices based on microfluidics by developing a regulatory science tool for leakage testing.
Furthermore, microfluidics entails high levels of skill, and therefore, simplifying through machine learning and AI can encourage its broader use in life sciences and healthcare. For instance, Deepcell, with its AI-based single-cell sorting and analysis technology, is among the first companies to bring the combination of machine learning, AI, and microfluidics into the commercial domain.
- U.S. Microfluidics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Microfluidic Components
- Microfluidic-based Devices
- U.S. Microfluidics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Lab-on-a-Chip
- Continuous Flow Microfluidics
- Electrophoresis and Microfluidics
- Acoustofluidics and Microfluidics
- Optofluidics and Microfluidics
- Organ-on-a-Chip
- U.S. Microfluidics Market Material Type Outlook (Revenue, USD Million , 2021-2033)
- PDMS
- Glass
- Polymer
- Silicon
- Others
- U.S. Microfluidics Market Application Outlook (Revenue, USD Million , 2021-2033)
- Medical
- Non-medical
Reasons to subscribe to Microfluidics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Microfluidics Market Outlook databook
- Our clientele includes a mix of Microfluidics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Microfluidics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Microfluidics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Microfluidics Market, 2021-2033 (US$M)
U.S. microfluidics market statistics, by product, 2021-2033 (US$M)
